Results 51 to 60 of about 4,366,481 (288)
This study advances SafeWax, a bio‐inspired, fatty‐acids‐based superhydrophobic coating, by identifying an agriculturally compliant solvent and revealing how solvent‐controlled Fatty acid crystallization governs the coating's microscopic structure and performance.
Niv Ben‐Arie +13 more
wiley +1 more source
Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. [PDF]
BACKGROUND: Most malaria-endemic countries are implementing a change in anti-malarial drug policy to artemisinin-based combination therapy (ACT). The impact of different drug choices and implementation strategies is uncertain.
Hastings, Ian M +21 more
core +1 more source
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors [PDF]
CYP51 (Erg11) belongs to the cytochrome P450 monooxygenase (CYP) superfamily and mediates a crucial step of the synthesis of ergosterol, which is a fungal-specific sterol. It is also the target of azole drugs in clinical practice. In recent years, researches on fungal CYP51 have stepped into a new stage attributing to the discovery of crystal ...
Jingxiang Zhang +8 more
openaire +3 more sources
Melanin content directly controls fungal spore mechanical properties, with pigmented spores achieving rupture forces two orders of magnitude higher than hyaline spores. Environmental stress drives this quantity‐quality tradeoff; stressed species invest energy in melanin‐reinforced, mechanically superior thick‐walled, super‐hydrophobic spores, while ...
Atul Agrawal, Steven E. Naleway
wiley +1 more source
Diseases caused by fungi can occur in healthy people, but immunocompromised patients are the major risk group for invasive fungal infections. Cases of fungal resistance and the difficulty of treatment make fungal infections a public health problem.
Juliana Alves Parente-Rocha +6 more
doaj +1 more source
Hsp90's role in fungal drug resistance.
Compromising Hsp90 function enhances the activity of fungistatic antifungal drugs, creating fungicidal drug combinations, and can block the evolution of drug resistance. Middle panel, left column indicates that in a wild-type fungal cell (shown in yellow)
Leah E. Cowen (108693)
core +1 more source
Engineering Antigen Density on M13 Bacteriophage for Personalized Nanovaccine
Increasing antigen density on the phage capsid impacts phage uptake and antigen cross‐presentation by antigen‐presenting cells, leading to enhanced activation of antitumor CD8+ T cells in the draining lymph nodes. These activated CD8+ T cells subsequently recognize the antigen‐expressing tumors and mediate their specific cytotoxic killing, thereby ...
Shengnan Huang +7 more
wiley +1 more source
Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease [PDF]
SUMMARY Pathogenic fungi have become a leading cause of human mortality due to the increasing frequency of fungal infections in immunocompromised populations and the limited armamentarium of clinically useful antifungal drugs.
Rebecca S, Shapiro +2 more
openaire +2 more sources
Control of Bacterial Attachment on Macroporous PDMS/Paraffin SLIPS With Varying Lubricant Viscosity
Slippery liquid‐infused porous surfaces (SLIPS) prepared from macroporous PDMS, infused with medical‐grade paraffins, were systematically investigated regarding the correlation of viscosity, surface corrugation, bulk porosity, and bacterial resistance. Substrate porosity was found to dominate lubricant stabilization and the antifouling activity.
Regina Kopecz +3 more
wiley +1 more source
_M. tuberculosis_ interactome analysis unravels potential pathways to drug resistance [PDF]
Drug resistance is a major problem for combating tuberculosis. Lack of understanding of how resistance emerges in bacteria upon drug treatment limits our ability to counter resistance.
Nagasuma Chandra, Karthik Raman
core

